We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Vienna, Austria

ESTRO 2023

Session

Biomarkers
6015
Poster (Digital)
Clinical
MULTICENTE ASSESSMENT OF SNPs(HSPβ1) FOR HEMATOLOGICAL TOXICITY IN LUNG CANCER (HEMATOLUNG PROJECT)
Oscar Muñoz Muñoz, Spain
PO-1438
CIRT-induced cardiac biomarkers changes in patients with para/intra-cardiac tumours
Amelia Barcellini, Italy
PO-1439
Biomarker correlates of MC ROR1771: Prospective Proton SBRT and Nivolumab for Metastatic H&N Cancer
Daniel Ebner, USA
PO-1442
Could Blood tests have prognostic value in Glioma patients? A mono-institutional experience
Marco Lucarelli, Italy
PO-1443
Dynamic neutrophil-to-lymphocyte ratio - a new predictive biomarker for recurrent sarcomas?
Constanza Martinez, Canada
PO-1444
Pituitary transforming tumor gene (PTTG). A new biomarker for lung adenocarcinoma?
Oscar Muñoz Muñoz, Spain
PO-1445
Systematic Review of Prognostic and Predictive Biomarkers in HNSCC Treated with Radiotherapy
Daniel Schanne, Switzerland
PO-1446
Exploration of serum citrulline as a predictive biomarker for late bowel toxicity in prostate SABR.
Orla Houlihan, United Kingdom
PO-1447
Perfusion MRI and MRI spectroscopy: biomarkers of memory decline in pediatric brain tumor survivors
Fatima TENSAOUTI, France
PO-1448
Hsa-miR-3651 could serve as a novel predictor for in-breast recurrence via FRMD3
Elvis Ruznic, Austria
PO-1450
Neutrophil-lymphocyte ratio dynamics associated with survival after SBRT for stage I-II lung cancer
Sahar Shahamatdar, USA
PO-1451